AXIN2, axin 2, 8313

N. diseases: 169; N. variants: 34
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 GeneticVariation phenotype BEFREE We analysed this novel AXIN2 mutant, together with two reported AXIN2 mutants [c.1966C>T (p.Arg656Stop) and c.1994delG (p.Leu688Stop)] that cause colorectal cancer with and without oligodontia, to study the effect of the mutant p.His660Tyr on the Wnt/β-catenin signaling pathway and to compare the molecular pathogenesis of different AXIN2 mutants in tooth agenesis and carcinogenesis. 27090353 2016
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 AlteredExpression phenotype BEFREE Individuals over 50 years of age and those with high dietary arginine consumption had increased basal expression of CyclinD1, AXIN2, cMYC and CD133 (p value range 0 · 04 to <0 · 001) that, following grape ingestion, were reduced to levels seen in younger participants.The reduction in Wnt signaling and mucosal proliferation seen following short-term ingestion of 1/3-1 lb (0.15-0.45 kg) of grapes per day may reduce the risk of mutational events that can facilitate colon carcinogenesis. 26085034 2015
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 Biomarker phenotype BEFREE In this paper, the roles of AXIN2 in tumorigenesis, AXIN2 methylation, ubiquitination and siRNA/RNA regulation will be reviewed. 25504512 2015
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 GeneticVariation phenotype BEFREE Polymorphism of AXIN2, a component of Wnt signaling, has been shown to play a role in tumorigenesis and dysregulated in cancer cells. 21069480 2011
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 Biomarker phenotype BEFREE To explore the contribution of AXIN1, AXIN2 and beta-catenin, components of Wnt signaling pathway, to the carcinogenesis of gastric cancer (GC), we examined AXIN1, AXIN2 exon7 and CTNNB1 (encoding beta-catenin) exon3 mutations in 70 GCs. 18330950 2008
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 PosttranslationalModification phenotype BEFREE Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. 18372914 2008
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 PosttranslationalModification phenotype BEFREE These data indicate that epigenetic silencing of AXIN2 is specifically associated with carcinogenesis in MSI+ CRCs. 16247484 2006
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 Biomarker phenotype BEFREE We discuss this complex regulation in terms of axin2's function in carcinogenesis. 15885887 2006
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.090 GeneticVariation phenotype BEFREE In contrast, adenomatous polyposis coli (APC) and AXIN2 mutations were not involved in skin tumorigenesis. 14633602 2003